Identification of Subclinical Myocardial Dysfunction in Breast Cancer Patients with Metabolic Syndrome after Cancer-Related Comprehensive Therapy

Table 2

Multivariate analysis for LVEF in breast cancer patients with metabolic syndrome after treatment.

Factor	β	SE	value
Age	0.328	0.127	0.014
BMI	0.343	0.270	0.211
Anthracycline	−0.020	2.073	0.992
Trastuzumab	−1.442	1.901	0.453
Left-side radiotherapy	2.133	1.802	0.244